Detalhe da pesquisa
1.
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial.
Ann Oncol
; 27(8): 1585-93, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084954